JP2012509329A5 - - Google Patents

Download PDF

Info

Publication number
JP2012509329A5
JP2012509329A5 JP2011537526A JP2011537526A JP2012509329A5 JP 2012509329 A5 JP2012509329 A5 JP 2012509329A5 JP 2011537526 A JP2011537526 A JP 2011537526A JP 2011537526 A JP2011537526 A JP 2011537526A JP 2012509329 A5 JP2012509329 A5 JP 2012509329A5
Authority
JP
Japan
Prior art keywords
item
microcrystalline cellulose
binder
excipient
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011537526A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012509329A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/064498 external-priority patent/WO2010059534A2/en
Publication of JP2012509329A publication Critical patent/JP2012509329A/ja
Publication of JP2012509329A5 publication Critical patent/JP2012509329A5/ja
Pending legal-status Critical Current

Links

JP2011537526A 2008-11-19 2009-11-16 直接圧縮可能で高機能性な顆粒状の微結晶性セルロースベース賦形剤、それらの製造プロセスおよび使用 Pending JP2012509329A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11602508P 2008-11-19 2008-11-19
US61/116,025 2008-11-19
PCT/US2009/064498 WO2010059534A2 (en) 2008-11-19 2009-11-16 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof

Publications (2)

Publication Number Publication Date
JP2012509329A JP2012509329A (ja) 2012-04-19
JP2012509329A5 true JP2012509329A5 (cg-RX-API-DMAC7.html) 2012-12-20

Family

ID=42077071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011537526A Pending JP2012509329A (ja) 2008-11-19 2009-11-16 直接圧縮可能で高機能性な顆粒状の微結晶性セルロースベース賦形剤、それらの製造プロセスおよび使用

Country Status (13)

Country Link
US (1) US20110288146A1 (cg-RX-API-DMAC7.html)
EP (1) EP2376067A2 (cg-RX-API-DMAC7.html)
JP (1) JP2012509329A (cg-RX-API-DMAC7.html)
KR (1) KR20110089180A (cg-RX-API-DMAC7.html)
CN (1) CN102215825A (cg-RX-API-DMAC7.html)
AU (1) AU2009316812A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0921507A2 (cg-RX-API-DMAC7.html)
CA (1) CA2744142A1 (cg-RX-API-DMAC7.html)
IL (1) IL212955A0 (cg-RX-API-DMAC7.html)
MX (1) MX2011005168A (cg-RX-API-DMAC7.html)
SG (1) SG171752A1 (cg-RX-API-DMAC7.html)
TW (1) TW201023897A (cg-RX-API-DMAC7.html)
WO (1) WO2010059534A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101298788B1 (ko) * 2011-03-15 2013-08-22 보령제약 주식회사 안정성이 개선된 복합제제
US9642807B2 (en) * 2012-04-27 2017-05-09 Japan Corn Starch Co., Ltd Method for producing starch granules, and orally disinitegrating tablet
DK3482771T3 (da) 2013-03-14 2023-03-20 Nestle Sa Fremstilling af jordnøddeformuleringer til oral desensibilisering
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
US20150343075A1 (en) * 2014-06-02 2015-12-03 Aimmune Therapeutics Placebo formulations and uses thereof
CN104189915B (zh) * 2014-07-30 2016-08-10 上海新亚药业闵行有限公司 一种固体制剂预混剂及其制备方法
CN104258411A (zh) * 2014-09-19 2015-01-07 安徽山河药用辅料股份有限公司 一种硅化微晶纤维素复合辅料及其制备方法
CN106265077A (zh) * 2015-05-30 2017-01-04 天士力制药集团股份有限公司 一种中药浸膏雾化分散工艺及其制剂
JP6650750B2 (ja) * 2015-12-22 2020-02-19 アサヒグループ食品株式会社 錠剤の製造方法、錠剤原料用顆粒の製造方法、及び錠剤原料用顆粒
WO2020037151A1 (en) 2018-08-16 2020-02-20 Aimmune Therapeutics, Inc. Peanut oral immunotherapy with maintenance dose
US12226448B2 (en) 2018-12-20 2025-02-18 Société des Produits Nestlé S.A. Peanut oral immunotherapy dosing schedule for missed doses
US11229673B2 (en) 2019-05-10 2022-01-25 Société des Produits Nestlé S.A. Methods for improving the quality of life of a patient with a peanut allergy
KR20220027943A (ko) 2019-07-05 2022-03-08 스웨디쉬 매치 노스 유럽 에이비 니코틴 함유 입자를 포함하는 충전 재료를 포함하는 경구 파우치형 니코틴 제품
PH12022551038A1 (en) 2019-11-20 2023-05-29 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine particles
PL4018848T3 (pl) 2020-12-22 2024-11-25 Swedish Match North Europe Ab Wyrób w saszetkach do użytku doustnego zawierający materiał pokrywający przepuszczalny dla cieczy oraz materiał wypełniający
CN116036291B (zh) * 2022-08-31 2025-08-26 瑞普(天津)生物药业有限公司 一种具有增溶作用的组合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
CA2126441C (en) * 1991-12-30 1999-12-21 David F. Erkoboni Microcrystalline cellulose spheronization composition
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
DK1070740T3 (da) * 1999-07-19 2008-05-13 Fit Gmbh Co-forarbejdet polysaccharidprodukt med uoplöseligt carboxymethylcellulose
DE60120211T2 (de) * 2000-11-06 2007-04-12 Asahi Kasei Kabushiki Kaisha Zellulosepartikel für eine pharmazeutische zusammensetzung
CZ20032138A3 (cs) * 2001-02-05 2005-03-16 R. P. Scherer Technologies, Inc. Způsoby a prostředky pro zeslabení chuti farmaceuticky aktivních činidel
EP1845950A2 (en) * 2005-02-03 2007-10-24 Nycomed Pharma AS Fast wet-massing method for the preparation of calcium-containing compositions
WO2008020990A1 (en) * 2006-08-09 2008-02-21 Mallinckrodt Baker, Inc. New direct compressible excipient blend
EP2076250B1 (en) * 2006-10-27 2011-01-05 FMC Corporation Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations
MY164765A (en) * 2007-10-10 2018-01-30 Avantor Performance Mat Llc Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof

Similar Documents

Publication Publication Date Title
JP2012509329A5 (cg-RX-API-DMAC7.html)
JP2009502969A5 (cg-RX-API-DMAC7.html)
EP2554169B1 (en) Pharmaceutical preparation comprising phenylalanine derivative
JP6875501B2 (ja) Aktプロテインキナーゼ阻害剤を含む薬学的組成物
HK1209337A1 (en) Medicament-containing hollow particle
RU2009110253A (ru) Способ приготовления таблеток прамипексолдигидрохлорида, обладающих высокой стабильностью при хранении
CN102215825A (zh) 可直接压制的颗粒状的基于微晶纤维素的赋形剂、其制备方法及应用
JPWO2017170858A1 (ja) 溶出性に優れた経口製剤
WO2015110952A1 (en) Solid oral pharmaceutical compositions comprising ticagrelor or salt thereof
JP2004067606A (ja) イトラコナゾール経口投与製剤
JP2017122056A (ja) 医薬含有造粒物の製造方法
CN114344294B (zh) 一种产品性能稳定的替米沙坦口服固体制剂及其制备方法
CN101854921B (zh) 用于口服施用ppi的药物制剂
JP2019524683A (ja) 含量均一性が改善されたタムスロシン塩酸塩含有徐放性ペレットを含む経口用薬剤学的製剤
RS52053B (sr) Proces za pripremanje raspršivanjem osušenih formulacija tmc125
CN102846573B (zh) 水飞蓟宾双层缓释片及其制备方法
JP2012025683A (ja) 苦味を有する生理活性物質含有粒子の製造方法
JP5650956B2 (ja) 混合顆粒剤の製造方法
CN105193731A (zh) 布洛芬微粒、布洛芬制剂及制备方法
JP6216408B2 (ja) 固体剤形で非常に難溶性の薬物を調製する方法
RU2536258C1 (ru) Способ получения таблеток терифлуномида
JP6741118B2 (ja) 固形製剤
JP7233852B2 (ja) 変色が抑制された固形製剤
CN111888477A (zh) 一种贝达喹啉药物制剂
CN106692093A (zh) 一种琥珀酸美托洛尔缓释片及其制备方法